Divibank is a financing platform offering businesses access to growth capital.
Needle operates as an AI-driven platform for search and agent creation.
Faro provides inexpensive apparel through re-commerce, collaborating with fashion companies to reduce textile waste and dumping at the manufacturing and consumption levels.
Chemomab Ltd. is a clinical-stage biotechnology company based in Tel Aviv, Israel, specializing in the development of therapeutic antibodies for autoimmune and inflammatory diseases. The company focuses on discovering innovative treatments for fibrosis-related diseases that have significant unmet medical needs. Chemomab's lead product, CM-101, is a monoclonal antibody designed to inhibit the activity of CCL24, a soluble protein that plays a crucial role in promoting fibrosis and inflammation. CM-101 is currently under clinical development, with a particular emphasis on treating orphan diseases such as Primary Sclerosing Cholangitis and Systemic Sclerosis. The company is conducting three Phase 2 clinical trials for CM-101 in various fibrotic indications and anticipates reporting results from these studies in the near future.
Razor Group is a global consumer holding company that specializes in acquiring and scaling e-commerce brands. By leveraging substantial growth capital and extensive expertise in e-commerce, Razor aims to elevate these brands to the next level of development. The company employs advanced data analytics and custom-built technology to optimize its merger and acquisition process, identifying profitable brands that align with its strategic focus on specific product categories. Razor prioritizes long-term value enhancement, aiming to improve product quality and customer satisfaction. Through its in-house e-commerce and finance expertise, Razor Group seeks to ensure that the brands it acquires can achieve category leadership and deliver better customer experiences.
Transmutex is a Swiss company founded in 2019 that specializes in advanced nuclear technology aimed at significantly reducing the stockpile of existing nuclear waste. The company utilizes particle accelerators to transmute long-lived nuclear waste, transforming it into less harmful materials while simultaneously generating carbon-free energy. This innovative approach offers a solution to the challenges faced by traditional nuclear power plants, allowing for scalable energy production that can either be reintegrated into the energy grid or utilized for green hydrogen production. The team at Transmutex comprises physicists, computer scientists, and environmentalists, and builds upon technologies previously tested at CERN and the Paul Scherrer Institute.
Standard Bots is a New York-based company that specializes in developing robotics platforms for both industrial and domestic applications. Founded in 2011, the company focuses on creating advanced hardware and software solutions, including the RO1 robot, to enhance automation and productivity across various industries. Standard Bots designs its products to be intuitive and easily integrated into existing workflows, ensuring accessibility for businesses of all sizes. The company manufactures robotic arms and develops comprehensive systems that include software, firmware, electronics, and vision systems, allowing customers to implement affordable and easy-to-setup robotic solutions on their shop floors.
Pantheon Design specializes in creating advanced 3D printing systems aimed at revolutionizing medium-scale manufacturing. The company focuses on developing flexible manufacturing solutions that cater to hardware innovators and integrators. Its printers are designed to deliver end-use quality parts significantly faster and at a lower cost compared to traditional methods. Pantheon Design's technology boasts industry-leading tolerances, superior surface finishes, and mechanical properties, ensuring that clients can produce high-quality products with ease and efficiency. By streamlining the manufacturing process, Pantheon Design addresses the common challenges faced by businesses in the production of parts, ultimately enhancing productivity and reducing costs.
Tern Group is an AI Platform to hire and relocate top healthcare talents globally, faster and cheaper. TERN is a full-stack solution to source and relocate top-tier medical and engineering talent from India, North Africa, South Africa, and Central Asia and the approach ensures a seamless, ethical, and transparent migration process, drastically cutting complexity and shaving costs for healthcare systems.
Duetti is a music fintech company that specializes in providing financial solutions for independent musicians. The company acquires catalog rights from artists and monetizes these assets through data-driven strategies and social media marketing. Duetti aims to facilitate quick access to catalog sales, thereby unlocking new investment opportunities for a diverse range of musicians. By offering data-informed pricing for established tracks, the company enables artists to sell individual tracks or portions of their catalog. Duetti's approach not only supports musicians financially but also helps them achieve their professional and personal goals.
Razor Group is a global consumer holding company that specializes in acquiring and scaling e-commerce brands. By leveraging substantial growth capital and extensive expertise in e-commerce, Razor aims to elevate these brands to the next level of development. The company employs advanced data analytics and custom-built technology to optimize its merger and acquisition process, identifying profitable brands that align with its strategic focus on specific product categories. Razor prioritizes long-term value enhancement, aiming to improve product quality and customer satisfaction. Through its in-house e-commerce and finance expertise, Razor Group seeks to ensure that the brands it acquires can achieve category leadership and deliver better customer experiences.
Private Equity Round in 2022
Razor Group is a global consumer holding company that specializes in acquiring and scaling e-commerce brands. By leveraging substantial growth capital and extensive expertise in e-commerce, Razor aims to elevate these brands to the next level of development. The company employs advanced data analytics and custom-built technology to optimize its merger and acquisition process, identifying profitable brands that align with its strategic focus on specific product categories. Razor prioritizes long-term value enhancement, aiming to improve product quality and customer satisfaction. Through its in-house e-commerce and finance expertise, Razor Group seeks to ensure that the brands it acquires can achieve category leadership and deliver better customer experiences.
Commons is a company based in Oakland, California, that focuses on enabling individuals to track, reduce, and offset the carbon emissions associated with their purchases. Founded in 2018, it offers a consumer-friendly application that provides practical tools for building a more sustainable lifestyle. Users can view their emissions in real-time, discover strategies for reduction, and access a selection of high-quality carbon offsets. By converting everyday purchases into opportunities for climate action, Commons aims to empower individuals and communities to manage their climate impact effectively and contribute to a more sustainable economy.
Alto Neuroscience is a clinical-stage biopharmaceutical company focused on improving mental health treatment through personalized medicine. By utilizing an AI-enabled biomarker platform, Alto integrates detailed patient data regarding brain activity and behavior to develop effective therapeutics for specific populations. The company aims to transform the traditional trial-and-error approach in psychiatry by matching the appropriate treatment to individual patients, thereby enhancing the effectiveness of interventions. Alto's clinical-stage assets include various products targeting conditions such as depressive disorders and schizophrenia, identified through independent brain-based biomarkers. Through its innovative approach, Alto Neuroscience seeks to redefine psychiatric care at a critical time for mental health.
Hoxton Farms, located in London, UK, specializes in producing real animal fat without the use of animals. The company employs a combination of cell biology and mathematical modeling to cultivate purified animal fat in bioreactors. This innovative approach provides a sustainable and cruelty-free ingredient for the meat alternatives industry, as well as applications in other sectors such as bakery, confectionery, and cosmetics. By focusing on cultivated fat, Hoxton Farms aims to meet the growing demand for ethical and environmentally friendly food products.
Alloy Therapeutics is a biotechnology company founded in 2017 and headquartered in Waltham, Massachusetts. The firm specializes in democratizing access to drug discovery through its innovative platforms and services. Its flagship offering, Alloy-Gx, is a suite of immunocompetent transgenic mice designed for optimal in vivo human antibody discovery. This royalty-free platform allows researchers broad and non-exclusive access to essential drug discovery tools, streamlining the process of antibody project development. By providing these resources, Alloy Therapeutics aims to facilitate advancements in antibody research and ultimately enhance the drug discovery landscape.
Cleerly is a healthcare company whose mission is to create digital care pathways to prevent heart attacks. The company develops a new standard for coronary artery disease by integrating quality clinical science with the latest-generation AI, in order to offer actionable clinical insights to every stakeholder in the heart care pathway. Through these data-driven solutions, the company aims to provide a comprehensive solution for cardiovascular disease evaluation that offers value to the healthcare system and improves heart health for patients at risk of heart attacks.
Lilo is a leading invest-and-experience platform in Europe focused on fractional property ownership. It enables users to purchase shares in high-end residential properties located in sought-after cities across the continent. The platform provides exclusive access to a curated selection of premium properties, allowing members to own fractions of these assets, with ownership divided into up to eight shares. This model facilitates the assembly of a diverse global property portfolio while alleviating the financial and logistical challenges typically associated with property investment.
Duetti is a music fintech company that specializes in providing financial solutions for independent musicians. The company acquires catalog rights from artists and monetizes these assets through data-driven strategies and social media marketing. Duetti aims to facilitate quick access to catalog sales, thereby unlocking new investment opportunities for a diverse range of musicians. By offering data-informed pricing for established tracks, the company enables artists to sell individual tracks or portions of their catalog. Duetti's approach not only supports musicians financially but also helps them achieve their professional and personal goals.
Bamba is an android application allowing micro-merchants across Africa to run their entire business utilizing their phones. It focuses on simple tools for merchants to manage their customers, get paid, payout as well as takeout cash advances against their future cash flow.
Today, organizations spend a lot of money on physical data gathering exercises using old-fashioned paper-based methods. These methods result in expensive, severely delayed and incomplete data . With Bamba, a client can launch a data collection exercise anywhere in the world simply from the comfort of their web browser and the client can ensure individuals respond with complete answers by paying those individuals for that data with mobile airtime in 122 different countries thus far.
Earth is the creators of soil transformation, an environmentally-friendly alternative to burial and cremation. Over a 30-day process, they gently transform a body into nutrient-rich soil. Families receive a portion of this soil - to scatter or plant - and the remaining soil is sent to conservation land that we acquire, to restore and protect it for future generations. Their experience is carbon neutral, digital-first and underpinned by best-in-class family care. Earth is headquartered in Seattle, Washington and was founded in 2020.
RARIO is a non-fungible token (NFT) marketplace founded in 2021 and based in Singapore. It specializes in officially licensed cricket NFTs, allowing fans to buy, sell, and trade a variety of digital collectibles, including playing cards, video moments, and cricket artifacts. The platform enables users to engage with other cricket enthusiasts, participate in exclusive fan clubs, and take part in quests for rewards, while also offering opportunities to earn real money through trading. By making the digital collectible experience more accessible, RARIO aims to enhance fan engagement within the cricket community.
Rejuveron Life Sciences AG, founded in 2019 and based in Zug, Switzerland, is a biotechnology platform company focused on developing and investing in therapies and technologies aimed at enhancing healthy aging and extending lifespan. The company seeks to advance innovative solutions by investing in promising ideas and talented individuals within the field of life sciences.
SmithRx is a San Francisco-based company that specializes in designing and managing custom pharmacy benefit plans for employers. Founded in 2016, it operates on a modern technology platform that enhances flexibility, efficiency, and customer satisfaction in the pharmacy benefits space. The company aims to provide a cost-competitive pharmacy benefit management service through a pass-through model, a unified technology platform, and concierge-level support. By leveraging data analytics, SmithRx offers transparency and control over pharmacy benefits, enabling employers and their employees to better manage prescription costs. The team at SmithRx combines expertise from various healthcare and technology sectors, ensuring that clinical programs and alternative sourcing are effectively integrated into their service offerings. This approach not only focuses on reducing drug spending but also enhances the overall experience for members navigating their pharmacy benefits.
Valoreo acquires, operates, and scales outstanding e-commerce brands with superstar products. We focus on brands with excellent customer reviews and merchants that have proven success by being top-seller in niche categories with high-growth potential.
FORME Life is a modular smart home gym and home fitness system for fitness and strength workouts. The company combines advanced linked fitness devices with coaching and personal training provided by real people to provide an immersive experience and improve results for both clients and trainers.
Cloud Paper, Inc. is a manufacturer based in Seattle, Washington, that specializes in producing toilet paper from 100% bamboo, positioning itself as a tree-free paper alternative. Founded in 2019, the company is committed to sustainability, aiming to eliminate deforestation associated with traditional paper products. Cloud Paper's offerings are designed to be super-soft and are packaged using recycled materials, with a focus on avoiding plastic in their packaging. By promoting eco-friendly practices, Cloud Paper seeks to provide consumers with a more sustainable option for personal care products while addressing the environmental impact of conventional paper manufacturing. Products are available for purchase through the company's website.
Nana Delivery is an e-commerce and delivery platform that specializes in providing rapid grocery delivery services. By utilizing a network of dark stores strategically located in urban areas, the company ensures that products are stored close to consumers, which facilitates swift order fulfillment. Nana Delivery focuses exclusively on online orders, allowing for efficient selection, packaging, and dispatch of a wide variety of grocery items. This approach aims to enhance the grocery shopping experience by making it more convenient, affordable, and readily accessible for users.
Denario is a financial software developer focused on enhancing cash flow for small and medium-sized businesses (SMBs) and startups. Its integrated B2B payments platform automates essential financial processes, including the automatic receipt of invoices, payment approvals, and scheduling. This streamlining of monthly accounting tasks allows clients to manage and monitor their financial transactions efficiently and securely in one centralized location. By simplifying payment management, Denario aims to improve the overall financial health of its clients.
Enable Medicine is a biotechnology company based in Menlo Park, California, founded in 2019 by Aaron Mayer and Sunil Bodapati. The company specializes in spatial biology data, offering a cloud-based platform that facilitates the generation, management, and analysis of various biological image formats. Enable Medicine's platform provides end-to-end services, including custom panel development and advanced imaging technology, which support researchers, drug developers, and physicians in creating detailed cellular maps. This comprehensive approach enables users to extract valuable insights from diverse sample types, thereby accelerating the drug discovery process and reducing associated costs.
Koniku Inc. is a neurotechnology company based in Berkeley, California, established in 2015. It specializes in developing co-processors made from biological neurons, which enable computers to detect and analyze odors. The company's primary innovation is the Konikore, a smell processor that has applications in various fields, including healthcare, security, industrial monitoring, and food safety. By capturing volatile organic compounds (VOCs) in environments like bathrooms, Koniku aims to create a data network that can predict disease outcomes before they manifest, utilizing machine learning to analyze the collected data. Additionally, Koniku provides preclinical testing services that replicate the sensitivity of biological systems, facilitating the development of devices that can monitor and map interactions with VOCs in human life.
Peek Travel, Inc. is a travel activities marketplace based in San Francisco, California, specializing in tour operator software that facilitates the discovery and booking of tours and activities across the United States. Founded in 2011, Peek offers a platform that connects customers with a curated selection of experiences, allowing users to easily book activities online. The company empowers operators by providing them with tools to manage and grow their businesses effectively. Peek's website and mobile app serve as marketing channels, generating new customer interest by making thousands of activities accessible and bookable anytime, anywhere. Through its technology, Peek aims to create lasting memories for travelers by connecting them with everyday adventures.
Divibank is a financing platform offering businesses access to growth capital.
Bound is a fintech company that makes FX management easy for every business. The company was founded by Seth Phillips and Daniel Kindler in 2020.
Lindus Health is a clinical research organization focused on delivering comprehensive clinical trial services for health and biotech companies. The company offers a range of solutions, including ethics and IRB submission, trial monitoring, data management, biostatistics, regulatory support, and payer affairs. By utilizing a proprietary software platform, Lindus Health automates various aspects of the clinical trial workflow, which streamlines operations and minimizes manual inefficiencies. This platform also facilitates access to electronic health records, enhancing patient recruitment and clinical data capture. Furthermore, Lindus Health leverages real-world patient data to improve trial design and execution, ultimately aiming to accelerate the clinical trial process while reducing risks and costs associated with trial failures.
Una Brands, founded in 2020 and based in Singapore, specializes in acquiring and transforming e-commerce businesses into globally recognized brands. The company focuses on purchasing category-winning brands with proven performance, high product quality, and positive customer feedback. By leveraging significant growth capital, Una Brands aims to accelerate the development of these businesses, ensuring they become enduring household names. Utilizing data analytics and an AI platform, Una Brands optimizes and automates operational processes, providing a competitive advantage in the e-commerce landscape.
Blackrock Neurotech specializes in developing advanced neurotechnology platforms that record bio-potentials from both the central and peripheral nervous systems. Their precision electrode technology plays a crucial role in brain-computer interfaces and neural signal processing, enabling innovations that assist individuals with disabilities to walk, talk, see, hear, and feel. The company focuses on translating these technological advancements into novel, implantable clinical solutions aimed at enhancing human lives. By providing the clinical community with innovative tools and neurotech expertise, Blackrock Neurotech contributes significantly to the advancement of neurotechnology applications in both chronic and acute settings.
Grounded Foods Co. is a West Hollywood-based company that specializes in producing plant-based cheeses made from cauliflower and hemp seeds. Its product offerings include gruyere style cheese, camembert style cheese, marinated hemp seed feta, and hemp seed cream cheese, all crafted through a proprietary fermentation process. This innovative approach allows the products to closely mimic the flavor and texture of traditional dairy cheese while providing high nutritional value and promoting environmental sustainability. Founded in 2019 by Australian entrepreneurs Veronica Fil, a behavioral economist, and Shaun Quade, an internationally acclaimed chef, the company aims to make dairy-free cheese accessible to a wider audience through both retail and online sales.
Perfect Day produces dairy proteins that are nutritionally identical to proteins from cow’s milk. Perfect Day is pioneering a whole new era in animal-free dairy products. One the delivers all of the taste, texture, and nutrition of dairy with none of the food safety, environmental, or animal welfare downsides. The company's animal-free approach, based on the safe and proven techniques that give the consumers beer or vegetarian rennet also provides consumers and food manufacturers with the same product they all know and love - through a more sustainable and compassionate process. It was founded in 2014 and is headquartered in Emeryville, California.
Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel neuroplasticity-promoting therapeutics—to better treat mental health disorders at scale. The company was founded in 2019 and is headquartered in Boston, Massachusetts.
Razor Group is a global consumer holding company that specializes in acquiring and scaling e-commerce brands. By leveraging substantial growth capital and extensive expertise in e-commerce, Razor aims to elevate these brands to the next level of development. The company employs advanced data analytics and custom-built technology to optimize its merger and acquisition process, identifying profitable brands that align with its strategic focus on specific product categories. Razor prioritizes long-term value enhancement, aiming to improve product quality and customer satisfaction. Through its in-house e-commerce and finance expertise, Razor Group seeks to ensure that the brands it acquires can achieve category leadership and deliver better customer experiences.
UpScalio is an eCommerce brand investor and operator that provides financial services to invest in, grow, and buy businesses. It provides funds to digital brands selling on eCommerce marketplaces like Amazon, Myntra, Flipkart and Nykaa and manages key operations for them including multi-marketplace management, digital marketing, branding, logistics, sourcing, finance, and business operations.
Penta Fintech Ltd. is a digital banking platform based in Berlin, Germany, that caters to startups and small to medium-sized enterprises (SMEs). Founded in 2016, Penta offers a streamlined approach to banking by automating bank accounts and invoices, which helps businesses save time and money. The platform enables users to open online banking accounts quickly and manage their cash flows efficiently through cashless banking services. Penta aims to disrupt traditional business banking in Europe and beyond by providing innovative solutions tailored to the needs of self-employed individuals, freelancers, startups, and SMEs.
Transmutex is a Swiss company founded in 2019 that specializes in advanced nuclear technology aimed at significantly reducing the stockpile of existing nuclear waste. The company utilizes particle accelerators to transmute long-lived nuclear waste, transforming it into less harmful materials while simultaneously generating carbon-free energy. This innovative approach offers a solution to the challenges faced by traditional nuclear power plants, allowing for scalable energy production that can either be reintegrated into the energy grid or utilized for green hydrogen production. The team at Transmutex comprises physicists, computer scientists, and environmentalists, and builds upon technologies previously tested at CERN and the Paul Scherrer Institute.
TMRW Life Sciences is a technology company focused on improving standards of safety, transparency, and accountability in the management of frozen eggs and embryos within the IVF sector. The company has developed the first automated cryo-management platform specifically designed for this purpose, which integrates a digital chain of custody with robotic storage and monitoring solutions. This innovative approach aims to replace traditional manual methods that have remained largely unchanged over the years, thereby significantly reducing the risk of errors that could have serious consequences. Founded in 2018 by Joshua Abram, Alan Murray, and Dr. Jeffrey Port, TMRW combines expertise in fertility, embryology, cryo-management, automation, software development, and robotics to enhance the specimen management process for clinics, facilitating advancements in IVF technology. The company is headquartered in New York, New York.
Syfe is an investment and savings platform that empowers individuals to build their wealth through a comprehensive range of services. It offers fully managed portfolios, cash management solutions, and self-directed investment options, making it a unique all-in-one wealth management platform in the region. The company is fully licensed for fund management, financial advisory, and brokerage in Singapore, Hong Kong, and Australia. Syfe utilizes a proprietary algorithm to tailor portfolios for each client, optimizing returns while managing risk, thus providing customized and globally diversified investment strategies that align with individual risk profiles. The company has secured funding from notable investors, indicating strong market confidence in its innovative approach to wealth management.
UpScalio is an eCommerce brand investor and operator that provides financial services to invest in, grow, and buy businesses. It provides funds to digital brands selling on eCommerce marketplaces like Amazon, Myntra, Flipkart and Nykaa and manages key operations for them including multi-marketplace management, digital marketing, branding, logistics, sourcing, finance, and business operations.
Umoja Biopharma specializes in innovative immunotherapy aimed at transforming cancer treatment and enhancing patient quality of life. The company focuses on reprogramming T cells within the patient's body to effectively target cancer, including solid tumors and hematological cancers that often have poor responses to conventional therapies. Its proprietary CAR T-cell gene therapy platform is designed to deliver scalable therapeutic regimens tailored to various stages of cancer, enabling medical practitioners to directly and safely attack cancer cells. By harnessing the body's immune response, Umoja Biopharma seeks to improve overall patient outcomes and provide more effective treatment options for those affected by cancer.
Blackrock Neurotech specializes in developing advanced neurotechnology platforms that record bio-potentials from both the central and peripheral nervous systems. Their precision electrode technology plays a crucial role in brain-computer interfaces and neural signal processing, enabling innovations that assist individuals with disabilities to walk, talk, see, hear, and feel. The company focuses on translating these technological advancements into novel, implantable clinical solutions aimed at enhancing human lives. By providing the clinical community with innovative tools and neurotech expertise, Blackrock Neurotech contributes significantly to the advancement of neurotechnology applications in both chronic and acute settings.
Una Brands, founded in 2020 and based in Singapore, specializes in acquiring and transforming e-commerce businesses into globally recognized brands. The company focuses on purchasing category-winning brands with proven performance, high product quality, and positive customer feedback. By leveraging significant growth capital, Una Brands aims to accelerate the development of these businesses, ensuring they become enduring household names. Utilizing data analytics and an AI platform, Una Brands optimizes and automates operational processes, providing a competitive advantage in the e-commerce landscape.
Una Brands, founded in 2020 and based in Singapore, specializes in acquiring and transforming e-commerce businesses into globally recognized brands. The company focuses on purchasing category-winning brands with proven performance, high product quality, and positive customer feedback. By leveraging significant growth capital, Una Brands aims to accelerate the development of these businesses, ensuring they become enduring household names. Utilizing data analytics and an AI platform, Una Brands optimizes and automates operational processes, providing a competitive advantage in the e-commerce landscape.
Valoreo acquires, operates, and scales outstanding e-commerce brands with superstar products. We focus on brands with excellent customer reviews and merchants that have proven success by being top-seller in niche categories with high-growth potential.
Razor Group is a global consumer holding company that specializes in acquiring and scaling e-commerce brands. By leveraging substantial growth capital and extensive expertise in e-commerce, Razor aims to elevate these brands to the next level of development. The company employs advanced data analytics and custom-built technology to optimize its merger and acquisition process, identifying profitable brands that align with its strategic focus on specific product categories. Razor prioritizes long-term value enhancement, aiming to improve product quality and customer satisfaction. Through its in-house e-commerce and finance expertise, Razor Group seeks to ensure that the brands it acquires can achieve category leadership and deliver better customer experiences.
fortú is the personal finance platform for Latinos and Hispanics
Alto Neuroscience is a clinical-stage biopharmaceutical company focused on improving mental health treatment through personalized medicine. By utilizing an AI-enabled biomarker platform, Alto integrates detailed patient data regarding brain activity and behavior to develop effective therapeutics for specific populations. The company aims to transform the traditional trial-and-error approach in psychiatry by matching the appropriate treatment to individual patients, thereby enhancing the effectiveness of interventions. Alto's clinical-stage assets include various products targeting conditions such as depressive disorders and schizophrenia, identified through independent brain-based biomarkers. Through its innovative approach, Alto Neuroscience seeks to redefine psychiatric care at a critical time for mental health.
Angiex was founded by world-class scientists to develop vascular-targeted biotherapeutics. Angiex targets fundamental aspects of endothelial biology with a focus on angiogenesis. Angiex’s lead product is an antibody-drug conjugate therapy for cancer. Angiex was launched with IP from Beth Israel Deaconess Medical Center, is resident at LabCentral in Cambridge.
Alloy Therapeutics is a biotechnology company founded in 2017 and headquartered in Waltham, Massachusetts. The firm specializes in democratizing access to drug discovery through its innovative platforms and services. Its flagship offering, Alloy-Gx, is a suite of immunocompetent transgenic mice designed for optimal in vivo human antibody discovery. This royalty-free platform allows researchers broad and non-exclusive access to essential drug discovery tools, streamlining the process of antibody project development. By providing these resources, Alloy Therapeutics aims to facilitate advancements in antibody research and ultimately enhance the drug discovery landscape.
Chemomab Ltd. is a clinical-stage biotechnology company based in Tel Aviv, Israel, specializing in the development of therapeutic antibodies for autoimmune and inflammatory diseases. The company focuses on discovering innovative treatments for fibrosis-related diseases that have significant unmet medical needs. Chemomab's lead product, CM-101, is a monoclonal antibody designed to inhibit the activity of CCL24, a soluble protein that plays a crucial role in promoting fibrosis and inflammation. CM-101 is currently under clinical development, with a particular emphasis on treating orphan diseases such as Primary Sclerosing Cholangitis and Systemic Sclerosis. The company is conducting three Phase 2 clinical trials for CM-101 in various fibrotic indications and anticipates reporting results from these studies in the near future.
ATAI Life Sciences AG is a biotechnology company based in Munich, Germany, with additional offices in Berlin and London, established in 2018. The company focuses on developing therapies for mental health disorders, utilizing psychedelic compounds and other innovative methods to address conditions such as depression, anxiety, and substance use disorders. ATAI collaborates with various partners and research institutions to advance its clinical-stage drug development pipeline, which includes multiple product candidates like psilocybin therapy, ketamine-based treatments, and other compounds aimed at enhancing mental well-being. The company's commitment to research in psychedelics and neuroscience drives its efforts to ensure the efficacy and safety of its therapies. Recognized for its contributions to mental health treatment, ATAI has secured partnerships and funding to support its initiatives, gaining attention for its advancements in understanding and treating mental health disorders.
Penta Fintech Ltd. is a digital banking platform based in Berlin, Germany, that caters to startups and small to medium-sized enterprises (SMEs). Founded in 2016, Penta offers a streamlined approach to banking by automating bank accounts and invoices, which helps businesses save time and money. The platform enables users to open online banking accounts quickly and manage their cash flows efficiently through cashless banking services. Penta aims to disrupt traditional business banking in Europe and beyond by providing innovative solutions tailored to the needs of self-employed individuals, freelancers, startups, and SMEs.
Valoreo acquires, operates, and scales outstanding e-commerce brands with superstar products. We focus on brands with excellent customer reviews and merchants that have proven success by being top-seller in niche categories with high-growth potential.
Hoxton Farms, located in London, UK, specializes in producing real animal fat without the use of animals. The company employs a combination of cell biology and mathematical modeling to cultivate purified animal fat in bioreactors. This innovative approach provides a sustainable and cruelty-free ingredient for the meat alternatives industry, as well as applications in other sectors such as bakery, confectionery, and cosmetics. By focusing on cultivated fat, Hoxton Farms aims to meet the growing demand for ethical and environmentally friendly food products.
NewAmsterdam Pharma is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for cardio-metabolic diseases. The company aims to enhance patient care for individuals with metabolic disorders by addressing the shortcomings of currently available treatments. Its leading product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor designed to effectively lower LDL cholesterol levels while potentially overcoming the limitations associated with existing therapies.
Sensei Biotherapeutics is a clinical-stage biotechnology company based in Gaithersburg, Maryland, with an additional office in Boston, Massachusetts. The company is dedicated to developing precision cancer therapeutics that target tumor-specific antigens, focusing on next-generation cancer immunotherapies. Utilizing its proprietary ImmunoPhage platform, Sensei Biotherapeutics creates immune-activating agents designed to engage both innate and adaptive immune systems. The company's TMAb (Tumor Microenvironment Activated Biologics) platform aims to develop selective therapeutics that either disable immunosuppressive signals or activate immunostimulatory signals within the tumor microenvironment. Sensei Biotherapeutics is advancing four investigational product candidates, including SNS-101, SNS-102, SNS-103, and SNS-20, which are in various stages of development. The company brings together expertise in biology, immunology, and oncology, supported by a seasoned management team and scientific advisors, to address unmet needs in cancer treatment.
Peptilogics, Inc. is a biotechnology company based in West Mifflin, Pennsylvania, that focuses on developing novel peptide therapeutics to combat multidrug-resistant bacterial infections. Established in 2013, Peptilogics employs a unique computational platform that facilitates drug discovery by exploring new chemical design spaces and ensuring the biological viability and manufacturability of potential therapeutics. The company's lead candidate, PLG0206, is a broad-spectrum anti-infective peptide that has received FDA Orphan Drug Designation and Qualified Infectious Disease Product Designation, targeting prosthetic joint infections, which represent a significant unmet medical need. Peptilogics aims to provide effective solutions to address the challenges posed by resistant bacteria and biofilms, ultimately improving treatment outcomes for patients.
Rational Vaccines is a preclinical stage company focused on developing innovative vaccines to combat herpes simplex virus and its related diseases. The company is dedicated to creating live-attenuated viral immunotherapeutic and prophylactic vaccine candidates that aim to reduce the transmission of the herpes virus and effectively manage symptoms associated with its reactivation. By harnessing rational engineering techniques, Rational Vaccines seeks to revolutionize the treatment, prevention, and diagnosis of herpes infections, ultimately improving the quality of life for those affected by these conditions.
ATAI Life Sciences AG is a biotechnology company based in Munich, Germany, with additional offices in Berlin and London, established in 2018. The company focuses on developing therapies for mental health disorders, utilizing psychedelic compounds and other innovative methods to address conditions such as depression, anxiety, and substance use disorders. ATAI collaborates with various partners and research institutions to advance its clinical-stage drug development pipeline, which includes multiple product candidates like psilocybin therapy, ketamine-based treatments, and other compounds aimed at enhancing mental well-being. The company's commitment to research in psychedelics and neuroscience drives its efforts to ensure the efficacy and safety of its therapies. Recognized for its contributions to mental health treatment, ATAI has secured partnerships and funding to support its initiatives, gaining attention for its advancements in understanding and treating mental health disorders.
Razor Group is a global consumer holding company that specializes in acquiring and scaling e-commerce brands. By leveraging substantial growth capital and extensive expertise in e-commerce, Razor aims to elevate these brands to the next level of development. The company employs advanced data analytics and custom-built technology to optimize its merger and acquisition process, identifying profitable brands that align with its strategic focus on specific product categories. Razor prioritizes long-term value enhancement, aiming to improve product quality and customer satisfaction. Through its in-house e-commerce and finance expertise, Razor Group seeks to ensure that the brands it acquires can achieve category leadership and deliver better customer experiences.
Razor Group is a global consumer holding company that specializes in acquiring and scaling e-commerce brands. By leveraging substantial growth capital and extensive expertise in e-commerce, Razor aims to elevate these brands to the next level of development. The company employs advanced data analytics and custom-built technology to optimize its merger and acquisition process, identifying profitable brands that align with its strategic focus on specific product categories. Razor prioritizes long-term value enhancement, aiming to improve product quality and customer satisfaction. Through its in-house e-commerce and finance expertise, Razor Group seeks to ensure that the brands it acquires can achieve category leadership and deliver better customer experiences.
Angiex was founded by world-class scientists to develop vascular-targeted biotherapeutics. Angiex targets fundamental aspects of endothelial biology with a focus on angiogenesis. Angiex’s lead product is an antibody-drug conjugate therapy for cancer. Angiex was launched with IP from Beth Israel Deaconess Medical Center, is resident at LabCentral in Cambridge.
Sensei Biotherapeutics is a clinical-stage biotechnology company based in Gaithersburg, Maryland, with an additional office in Boston, Massachusetts. The company is dedicated to developing precision cancer therapeutics that target tumor-specific antigens, focusing on next-generation cancer immunotherapies. Utilizing its proprietary ImmunoPhage platform, Sensei Biotherapeutics creates immune-activating agents designed to engage both innate and adaptive immune systems. The company's TMAb (Tumor Microenvironment Activated Biologics) platform aims to develop selective therapeutics that either disable immunosuppressive signals or activate immunostimulatory signals within the tumor microenvironment. Sensei Biotherapeutics is advancing four investigational product candidates, including SNS-101, SNS-102, SNS-103, and SNS-20, which are in various stages of development. The company brings together expertise in biology, immunology, and oncology, supported by a seasoned management team and scientific advisors, to address unmet needs in cancer treatment.
Syfe is an investment and savings platform that empowers individuals to build their wealth through a comprehensive range of services. It offers fully managed portfolios, cash management solutions, and self-directed investment options, making it a unique all-in-one wealth management platform in the region. The company is fully licensed for fund management, financial advisory, and brokerage in Singapore, Hong Kong, and Australia. Syfe utilizes a proprietary algorithm to tailor portfolios for each client, optimizing returns while managing risk, thus providing customized and globally diversified investment strategies that align with individual risk profiles. The company has secured funding from notable investors, indicating strong market confidence in its innovative approach to wealth management.
Cloud Paper, Inc. is a manufacturer based in Seattle, Washington, that specializes in producing toilet paper from 100% bamboo, positioning itself as a tree-free paper alternative. Founded in 2019, the company is committed to sustainability, aiming to eliminate deforestation associated with traditional paper products. Cloud Paper's offerings are designed to be super-soft and are packaged using recycled materials, with a focus on avoiding plastic in their packaging. By promoting eco-friendly practices, Cloud Paper seeks to provide consumers with a more sustainable option for personal care products while addressing the environmental impact of conventional paper manufacturing. Products are available for purchase through the company's website.
Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel neuroplasticity-promoting therapeutics—to better treat mental health disorders at scale. The company was founded in 2019 and is headquartered in Boston, Massachusetts.
Razor Group is a global consumer holding company that specializes in acquiring and scaling e-commerce brands. By leveraging substantial growth capital and extensive expertise in e-commerce, Razor aims to elevate these brands to the next level of development. The company employs advanced data analytics and custom-built technology to optimize its merger and acquisition process, identifying profitable brands that align with its strategic focus on specific product categories. Razor prioritizes long-term value enhancement, aiming to improve product quality and customer satisfaction. Through its in-house e-commerce and finance expertise, Razor Group seeks to ensure that the brands it acquires can achieve category leadership and deliver better customer experiences.
Sorare is a Paris-based company that operates a global fantasy football game, allowing users to manage soccer teams using official digital collectible cards. Founded in December 2018, Sorare's platform utilizes blockchain technology to facilitate the trading of non-fungible tokens (NFTs), making it possible for fans to collect, buy, and sell virtual player cards. The platform aims to make cryptocurrency engaging and accessible through the lens of fantasy football. In December 2020, Sorare reported sales of $1.8 million in digital cards, highlighting its growing popularity in the realm of sports collectibles and online gaming.
Penta Fintech Ltd. is a digital banking platform based in Berlin, Germany, that caters to startups and small to medium-sized enterprises (SMEs). Founded in 2016, Penta offers a streamlined approach to banking by automating bank accounts and invoices, which helps businesses save time and money. The platform enables users to open online banking accounts quickly and manage their cash flows efficiently through cashless banking services. Penta aims to disrupt traditional business banking in Europe and beyond by providing innovative solutions tailored to the needs of self-employed individuals, freelancers, startups, and SMEs.
Alloy Therapeutics is a biotechnology company founded in 2017 and headquartered in Waltham, Massachusetts. The firm specializes in democratizing access to drug discovery through its innovative platforms and services. Its flagship offering, Alloy-Gx, is a suite of immunocompetent transgenic mice designed for optimal in vivo human antibody discovery. This royalty-free platform allows researchers broad and non-exclusive access to essential drug discovery tools, streamlining the process of antibody project development. By providing these resources, Alloy Therapeutics aims to facilitate advancements in antibody research and ultimately enhance the drug discovery landscape.
AbCellera is an antibody discovery and development company focused on overcoming the limitations of traditional discovery methods. By utilizing its integrated platform, AbCellera's experts rapidly search a diverse array of antibodies to identify the most effective candidates for clinical development. This streamlined approach allows for faster movement to clinical trials, ultimately benefiting patients sooner. The company has a strong track record of collaborating with both emerging biotechnology firms and established pharmaceutical companies, providing optimized solutions tailored to their needs. AbCellera employs proprietary technology and advanced data science to enhance its antibody discovery process, positioning itself as a strategic partner in the biopharmaceutical industry.
COMPASS Pathways plc is a mental health care company based in the United Kingdom and the United States, focusing on developing innovative therapies for treatment-resistant depression. The company is conducting Phase IIb clinical trials for its psilocybin formulation, COMP360, which aims to provide a new treatment option for patients who have not responded to conventional therapies. By researching psilocybin-assisted therapy, COMPASS Pathways seeks to assess its safety and efficacy, while combining the psychedelic compound with psychological support. The company was incorporated in 2020 and aims to address the significant unmet need for effective and accessible mental health treatments, striving to empower individuals facing mental health challenges.
AbCellera is an antibody discovery and development company focused on overcoming the limitations of traditional discovery methods. By utilizing its integrated platform, AbCellera's experts rapidly search a diverse array of antibodies to identify the most effective candidates for clinical development. This streamlined approach allows for faster movement to clinical trials, ultimately benefiting patients sooner. The company has a strong track record of collaborating with both emerging biotechnology firms and established pharmaceutical companies, providing optimized solutions tailored to their needs. AbCellera employs proprietary technology and advanced data science to enhance its antibody discovery process, positioning itself as a strategic partner in the biopharmaceutical industry.
EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClear’s proprietary therapeutic platform focuses on removing toxic proteins from the CSF. The company’s first products will target improving the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP).
Habitas is an experience-driven hospitality company that operates a global membership community centered around clubs and lifestyle hotels. Its locations include clubhouses in New York City and Los Angeles, along with a hotel in Tulum, Mexico. Additional properties are being developed in Malibu, the Bahamas, and Namibia. The company focuses on creating spaces that foster connection and community through events that celebrate shared interests such as music, food, and art. Additionally, Habitas is involved in charitable initiatives, including a program called RISE in Uganda, which underscores its commitment to social impact.
General Fusion Inc. is a Canadian company focused on the development of commercial Magnetized Target Fusion (MTF), a promising hybrid approach that combines elements of magnetic fusion and inertial confinement fusion. Founded in 2002 and based in Burnaby, the company aims to create utility-scale fusion power plants that can provide clean, safe, and abundant energy. General Fusion is pioneering a patent-pending concept that leverages advancements in MTF, which has seen limited exploration since the 1970s. The company is dedicated to demonstrating and commercializing this innovative energy solution by the end of the decade. It is supported by a network of global energy venture capital firms, industry leaders, and technology innovators, all working to reduce technical risks and accelerate the path to viable fusion energy.
Starship is a financial technology company based in New York City, established in 2016. It focuses on creating a mobile health savings account (HSA) platform that integrates savings, investing, and health-tracking tools. The application allows users to conveniently manage their health savings through automated investing in index funds, streamlined reimbursements, and a user-friendly mobile interface. Additionally, it offers features such as receipt management, card management, and family account oversight, facilitating tax-free healthcare expenses and promoting financial wellness. Starship aims to simplify the process of saving and investing for healthcare needs, making it accessible and efficient for users.
Chemomab Ltd. is a clinical-stage biotechnology company based in Tel Aviv, Israel, specializing in the development of therapeutic antibodies for autoimmune and inflammatory diseases. The company focuses on discovering innovative treatments for fibrosis-related diseases that have significant unmet medical needs. Chemomab's lead product, CM-101, is a monoclonal antibody designed to inhibit the activity of CCL24, a soluble protein that plays a crucial role in promoting fibrosis and inflammation. CM-101 is currently under clinical development, with a particular emphasis on treating orphan diseases such as Primary Sclerosing Cholangitis and Systemic Sclerosis. The company is conducting three Phase 2 clinical trials for CM-101 in various fibrotic indications and anticipates reporting results from these studies in the near future.
Karma Biotechnologies, Inc. is a Los Angeles-based startup focused on developing therapies for autoimmune diseases, allergies, and food sensitivities. Founded in 2019, the company offers Xavines, a precision immunotherapy platform designed to address the critical need for antigen-specific therapies that target only the rogue immune cells responsible for these conditions. Unlike traditional treatments that rely on general immune suppression, Karma Biotechnologies aims to create tolerogenic immunotherapies that promote antigen-specific immune tolerance in vivo. By leveraging its expertise in immunology and lipid nanoparticle engineering, the company seeks to provide innovative solutions that enhance the treatment landscape for autoimmune diseases and related disorders.
Deciduous Therapeutics is a biotechnology company focused on developing innovative immune-modulatory therapies aimed at treating age-related diseases. The company specializes in novel therapeutics that activate the body's natural immune surveillance mechanisms to selectively eliminate senescent cells, which are associated with various age-related health issues. By promoting the clearance of these cells, Deciduous Therapeutics seeks to enhance healthspan and potentially improve the quality of life for individuals experiencing the effects of aging. The company is led by Anil Bhushan, a professor at UCSF, and Robin Mansukhani, who has founded multiple biotech ventures.
EnClear Therapies is a Cambridge (USA) based life sciences company developing a device-based therapy to aid in the treatment of neurodegenerative disease and delivery and monitoring of cerebrospinal fluid (CSF). EnClear’s proprietary therapeutic platform focuses on removing toxic proteins from the CSF. The company’s first products will target improving the lives of patients with Amyotrophic Lateral Sclerosis (ALS) and Progressive Supranuclear Palsy (PSP).